Polar Capital Holdings »

Biomarin Pharma Inc convertible/ shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.9M 9.2M 0.97
2023-06-30 $17M 17M 0.98
2023-03-31 $18M 17M 1.03
2022-12-31 $18M 17M 1.06

More positions owned by Polar Capital Holdings

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Arch Cap Group Ord (ACGL)
Amazon (AMZN)
Renaissance Re Holdings Ltd Cmn (RNR)
Chubb (CB)
Servicenow (NOW)
Marsh & McLennan Companies (MMC)
Crowdstrike Hldgs Cl A (CRWD)
Hubspot (HUBS)

View all positions for Polar Capital Holdings

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/